cetylpyridinium has been researched along with Helicobacter Infections in 1 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiya, S | 1 |
| Taguchi, H | 1 |
1 review available for cetylpyridinium and Helicobacter Infections
| Article | Year |
|---|---|
[Prospect of the development of new bactericidal drugs against Helicobacter pylori for eradication therapy].
Topics: Animals; Anti-Bacterial Agents; Benzenesulfonates; Carbapenems; Cetylpyridinium; Drug Design; Drug R | 2002 |